Filing Details

Accession Number:
0001595585-20-000011
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-05 21:31:34
Reporting Period:
2020-02-03
Accepted Time:
2020-02-05 21:31:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1595585 Tricida Inc. TCDA Pharmaceutical Preparations (2834) 463372526
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1748808 Parsell Dawn Otto 7000 Shoreline Court, Suite 201
South San Francisco CA 94080
Sr Vp, Clinical Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-02-03 210 $1.68 465 No 4 M Direct
Common Stock Disposition 2020-02-03 210 $35.58 255 No 4 S Direct
Common Stock Acquisiton 2020-02-03 2,994 $1.68 3,249 No 4 M Direct
Common Stock Disposition 2020-02-03 258 $35.58 2,991 No 4 S Direct
Common Stock Disposition 2020-02-03 2,336 $36.74 655 No 4 S Direct
Common Stock Disposition 2020-02-03 400 $37.51 255 No 4 S Direct
Common Stock Acquisiton 2020-02-03 523 $2.39 778 No 4 M Direct
Common Stock Disposition 2020-02-03 523 $37.31 255 No 4 S Direct
Common Stock Acquisiton 2020-02-03 523 $7.49 778 No 4 M Direct
Common Stock Disposition 2020-02-03 523 $37.62 255 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2020-02-03 210 $0.00 210 $1.68
Common Stock Employee Stock Option (right to buy) Disposition 2020-02-03 2,994 $0.00 2,994 $1.68
Common Stock Employee Stock Option (right to buy) Disposition 2020-02-03 523 $0.00 523 $2.39
Common Stock Employee Stock Option (right to buy) Disposition 2020-02-03 523 $0.00 523 $7.49
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,050 2026-09-26 No 4 M Direct
11,806 2026-11-02 No 4 M Direct
18,321 2027-09-13 No 4 M Direct
24,602 2028-03-14 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2019.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.10 to $36.01, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4), (5) and (6) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.22 to $37.18, inclusive.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.31 to $37.72, inclusive.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.18 to $37.43, inclusive.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.43 to $37.70, inclusive.
  7. This option vested 25% on June 8, 2017, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase.
  8. This option vested 25% on October 1, 2017, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase.
  9. This option vests 25% on September 1, 2018, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase.
  10. This option vests 25% on March 15, 2019, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase.